{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:29:36Z","timestamp":1787596176801,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The objective of our study was to externally validate the value of the fibrinogen-to-albumin ratio (FAR), a new biomarker used to identify active inflammatory bowel disease (IBD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A total of 245 ulcerative colitis (UC) and 543 Crohn\u2019s disease (CD) patients were included in our study. Multivariate logistic regression analysis was used to investigate the independent association between FAR and disease activity in patients with UC or CD. The area under the receiver operating characteristic curve was used to assess the prediction accuracy of biomarkers in distinguishing disease states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariate logistic regression analysis identified the FAR as the strongest predictor to discriminate disease activity of UC (odds ratio: 24.871, 95% confidence interval: 9.831\u201338.912,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and CD (odds ratio: 28.966, 95% confidence interval: 21.009\u201337.250, p\u202f&amp;lt;\u202f0.001). The FAR gave the highest area under the curve in identifying both active UC (0.870, 95% confidence interval: 0.824\u20130.916) and CD (0.925, 95% confidence interval: 0.904\u20130.946). The probability of both UC and CD patients being in the active stage significantly increased when the FAR was more than or equal to the optimal cutoff values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The FAR, a simple prognostic indicator, performs well in identifying active IBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1460975","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:51:10Z","timestamp":1739929870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Fibrinogen-to-albumin ratio: a new biomarker to identify inflammatory bowel disease in active stage"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiao-Fu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.autrev.2019.03.002","article-title":"Induction and maintenance treatment of inflammatory bowel disease: a comprehensive review","volume":"18","author":"Jeong","year":"2019","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.autrev.2017.02.013","article-title":"IBD immunopathogenesis: a comprehensive review of inflammatory molecules","volume":"16","author":"Park","year":"2017","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and Management of Ulcerative Colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, Cancer surveillance, surgery, and Ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and Management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","article-title":"Current best practice for disease activity assessment in IBD","volume":"13","author":"Walsh","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.clinre.2012.06.004","article-title":"Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity","volume":"36","author":"Torun","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref9","first-page":"14779","article-title":"Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn\u2019s disease severity","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1515\/jomb-2017-0050","article-title":"Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis","volume":"37","author":"Akpinar","year":"2018","journal-title":"J Med Biochem"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/MIB.0000000000000427","article-title":"Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity","volume":"21","author":"Cherfane","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5009\/gnl.2011.5.4.460","article-title":"Red cell distribution width: a novel marker of activity in inflammatory bowel disease","volume":"5","author":"Ye\u015fil","year":"2011","journal-title":"Gut Liver"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/gut.2007.146357","article-title":"C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study","volume":"57","author":"Henriksen","year":"2008","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","article-title":"The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease","volume":"140","author":"Lewis","year":"2011","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10620-013-2907-3","article-title":"Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis","volume":"59","author":"Yoon","year":"2014","journal-title":"Dig Dis Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3748\/wjg.v20.i1.53","article-title":"Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability","volume":"20","author":"Owczarek","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ibd.20896","article-title":"Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation","volume":"15","author":"Yoshida","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12876-021-02040-9","article-title":"Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.advms.2018.08.001","article-title":"The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn\u2019s disease","volume":"64","author":"Daniluk","year":"2019","journal-title":"Adv Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool Lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and Meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/ibd\/izz053","article-title":"A nomogram combining fecal calprotectin levels and plasma cytokine profiles for individual prediction of postoperative Crohn\u2019s disease recurrence","volume":"25","author":"Cerrillo","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1515\/cclm-2016-0522","article-title":"Fecal calprotectin in inflammatory bowel diseases: update and perspectives","volume":"55","author":"Manceau","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/cs1020107","article-title":"The response of liver albumin synthesis to infection in rats varies with the phase of the inflammatory process","volume":"102","author":"Ruot","year":"2002","journal-title":"Clin Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1460975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:51:12Z","timestamp":1739929872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1460975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1460975"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1460975","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1460975"}}